In cancer, the TGFβ pathway is primary involved in the tumor evolution, mainly by promoting the epithelial-mesenchymal transition (EMT) [34, 38], a mechanism on which Fra-2 overexpression also converges [7, 39]. The gene discussed is FOSL2; the disease is neoplasm.